# Efficacy of Atorvastatin as Adjunctive Treatment for Chronic Plaque Type Psoriasis

> **NCT02432040** · PHASE2 · COMPLETED · sponsor: **Philippine Dermatological Society** · enrollment: 28 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** Atorvastatin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02432040
- **Lead sponsor:** Philippine Dermatological Society
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2013-10
- **Final completion:** 2013-11
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2015-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02432040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02432040, "Efficacy of Atorvastatin as Adjunctive Treatment for Chronic Plaque Type Psoriasis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02432040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*